Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study.
Frontiers in immunology（2023）
摘要
http://www.chictr.org.cn, Identifier ChiCTR2200061793.
更多查看译文
关键词
PD-L1 inhibitor,combination therapy,immunotherapy,intensity-modulated radiotherapy,macrovascular invasion
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要